Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson's disease.

作者: Mie Rizig , Oluwadamilola O Ojo , Alkyoni Athanasiou-Fragkouli , Osigwe P Agabi , Olajumoke O Oshinaike

DOI: 10.1016/J.NEUROBIOLAGING.2020.09.024

关键词: DiseaseEthnic groupGeneticsNigeriansBiologyPolymerase chain reactionMutationCohortGene mutationLRRK2

摘要: Abstract Leucine-rich repeat kinase 2 (LRRK2) gene mutations are the most common genetic cause of Parkinson's disease (PD). More than 300 rare LRRK2 variants have been described, with approximately 17 having confirmed or probable pathogenic role in PD. The distribution differs across ethnic groups, but no PD-related variant has described persons Black African ancestry within outside Africa. We previously reported absence p.Gly2019Ser mutation 126 PD and 55 controls from Nigeria. Using Kompetitive Allele Specific Polymerase Chain Reaction, we screened a new cohort 92 Nigerians 210 ethnically matched for 12 shown to be other populations, including p.Gly2019Ser, p.Arg1441His, p.Gly2385Arg, p.Ala419Val, p.Arg1628Pro, p.Pro755Leu, p.Ile2020Thr, Tyr1699Cys. All were absent controls, endorsing our previous findings confirming that Caucasians, Asians, mixed West Africans. Future studies applying next generation sequencing necessary explore novel indigenous

参考文章(34)
Ignacio F. Mata, Carolyn M. Hutter, María C. González-Fernández, Marian M. de Pancorbo, Elena Lezcano, Cecilia Huerta, Marta Blazquez, Renee Ribacoba, Luis M. Guisasola, Carlos Salvador, Juan C. Gómez-Esteban, Juan J. Zarranz, Jon Infante, Joseph Jankovic, Hao Deng, Karen L. Edwards, Victoria Alvarez, Cyrus P. Zabetian, Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics. ,vol. 10, pp. 347- 353 ,(2009) , 10.1007/S10048-009-0187-Z
Njideka Okubadejo, Angela Britton, Cynthia Crews, Rufus Akinyemi, John Hardy, Andrew Singleton, Jose Bras, Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3 PLoS ONE. ,vol. 3, pp. e3421- ,(2008) , 10.1371/JOURNAL.PONE.0003421
Hao Deng, WeiDong Le, Yi Guo, Christine B. Hunter, WenJie Xie, MaoSheng Huang, Joseph Jankovic, Genetic analysis of LRRK2 mutations in patients with Parkinson disease Journal of the Neurological Sciences. ,vol. 251, pp. 102- 106 ,(2006) , 10.1016/J.JNS.2006.09.017
Roberto Cilia, Francesca Sironi, Albert Akpalu, Momodou Cham, Fred Stephen Sarfo, Tiziana Brambilla, Alba Bonetti, Marianna Amboni, Stefano Goldwurm, Gianni Pezzoli, Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana. Journal of Neurology. ,vol. 259, pp. 569- 570 ,(2012) , 10.1007/S00415-011-6210-Y
A J Hughes, S E Daniel, L Kilford, A J Lees, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 55, pp. 181- 184 ,(1992) , 10.1136/JNNP.55.3.181
Hani T.S. Benamer, Rajith de Silva, LRRK2 G2019S in the North African population: a review. European Neurology. ,vol. 63, pp. 321- 325 ,(2010) , 10.1159/000279653
Rowena J. Keyser, Debbie Lombard, Rene Veikondis, Jonathan Carr, Soraya Bardien, Analysis of exon dosage using MLPA in South African Parkinson's disease patients. Neurogenetics. ,vol. 11, pp. 305- 312 ,(2010) , 10.1007/S10048-009-0229-6
Henry Houlden, Andrew B. Singleton, The genetics and neuropathology of Parkinson's disease. Acta Neuropathologica. ,vol. 124, pp. 325- 338 ,(2012) , 10.1007/S00401-012-1013-5
Taku Hatano, Manabu Funayama, Shin-ichiro Kubo, Ignacio F. Mata, Yutaka Oji, Akio Mori, Cyrus P. Zabetian, Sarah M. Waldherr, Hiroyo Yoshino, Genko Oyama, Yasushi Shimo, Ken-ichi Fujimoto, Hirokazu Oshima, Yasuto Kunii, Hirooki Yabe, Yoshikuni Mizuno, Nobutaka Hattori, Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease. Neurobiology of Aging. ,vol. 35, ,(2014) , 10.1016/J.NEUROBIOLAGING.2014.05.025